OpenAlex Citation Counts

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nanocarriers targeting the diseases of the pancreas
Nurbanu Demirtürk, Erem Bilensoy
European Journal of Pharmaceutics and Biopharmaceutics (2021) Vol. 170, pp. 10-23
Closed Access | Times Cited: 15

Showing 15 citing articles:

Inflammation and Acinar Cell Dual-Targeting Nanomedicines for Synergistic Treatment of Acute Pancreatitis via Ca²⁺ Homeostasis Regulation and Pancreas Autodigestion Inhibition
Yanan Wang, Xinyuan Wang, Xue Zhang, et al.
ACS Nano (2024) Vol. 18, Iss. 18, pp. 11778-11803
Closed Access | Times Cited: 16

Active targeting of type 1 diabetes therapies to pancreatic beta cells using nanocarriers
Jillian Collins, Nikki L. Farnsworth
Diabetologia (2025)
Closed Access

From micro to macro, nanotechnology demystifies acute pancreatitis: a new generation of treatment options emerges
Wei Du, Xinyue Wang, Yuyan Zhou, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access

Impairment of electron transport chain and induction of apoptosis by chrysin nanoparticles targeting succinate-ubiquinone oxidoreductase in pancreatic and lung cancer cells
Eman M. Ragab, Doaa M. El Gamal, Tarek M. Mohamed, et al.
Genes & Nutrition (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 10

S100P facilitates LUAD progression via PKA/c-Jun-mediated tumor-associated macrophage recruitment and polarization
Lu Gao, Ying Bai, Jiawei Zhou, et al.
Cellular Signalling (2024) Vol. 120, pp. 111179-111179
Closed Access | Times Cited: 3

A Review on the Efficacy and Safety of Nab-Paclitaxel with Gemcitabine in Combination with Other Therapeutic Agents as New Treatment Strategies in Pancreatic Cancer
Christian Chapa González, Karina López, Kimberly Michelle Lomelí, et al.
Life (2022) Vol. 12, Iss. 3, pp. 327-327
Open Access | Times Cited: 8

Hormone receptor binding, selectivity and cytotoxicity of steroid D-homo lactone loaded chitosan nanoparticles for the treatment of breast and prostate cancer cells
Ivana Kuzminac, Andjelka S. Ćelić, Sofija S. Bekić, et al.
Colloids and Surfaces B Biointerfaces (2022) Vol. 216, pp. 112597-112597
Open Access | Times Cited: 8

Research Progress of Antioxidant Nanomaterials for Acute Pancreatitis
Xiaoyi Zheng, Jiulong Zhao, Shige Wang, et al.
Molecules (2022) Vol. 27, Iss. 21, pp. 7238-7238
Open Access | Times Cited: 8

Rosiglitazone protects INS-1E cells from human islet amyloid polypeptide toxicity
Carine Marmentini, Dimitrius Santiago P.S.F. Guimarães, Tanes Lima, et al.
European Journal of Pharmacology (2022) Vol. 928, pp. 175122-175122
Closed Access | Times Cited: 7

Comprehensive review on polymeric and metal nanoparticles: possible therapeutic avenues
Raneev Thakur, Vimal Arora
International Journal of Polymeric Materials (2022) Vol. 72, Iss. 18, pp. 1489-1509
Closed Access | Times Cited: 5

Optimization and characterization of Rituximab targeted multidrug loaded cyclodextrin nanoparticles against Non-Hodgkin Lymphoma
Nurbanu Demirtürk, Gamze Varan, Sadık Kağa, et al.
International Journal of Pharmaceutics (2024) Vol. 662, pp. 124488-124488
Closed Access

Lipid-Based Mesoporous Silica Nanoparticles: A Paradigm Shift in Management of Pancreatic Cancer
Kiran Kumar Bellapu, Ramesh Joga, B Kannan, et al.
Pharmaceutical Patent Analyst (2023) Vol. 12, Iss. 6, pp. 261-273
Closed Access | Times Cited: 1

Metallic nanoparticles-based drug delivery for pancreatic cancer
Sara N. Moya Betancourt, Jorge G. Uranga, Viviana Daboin, et al.
Elsevier eBooks (2023), pp. 213-237
Closed Access

Special issue on the latest advances in regenerative medicine and cancer using drug delivery systems
Marı́a J. Blanco-Prı́eto, Elisa Garbayo
European Journal of Pharmaceutics and Biopharmaceutics (2022) Vol. 177, pp. 89-90
Closed Access

Biocompatible nanosponges for drug targeting in pancreatic cancer
Navni Sharma, Ritika Puri, Vimal Arora
Materials Today Proceedings (2022) Vol. 68, pp. 867-872
Closed Access

Page 1

Cookie	Duration	Description
cookielawinfo-checkbox-advertisement	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Advertisement" category .
cookielawinfo-checkbox-analytics	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Analytics" category .
cookielawinfo-checkbox-functional	1 year	The cookie is set by the GDPR Cookie Consent plugin to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Necessary" category .
cookielawinfo-checkbox-others	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to store the user consent for cookies in the category "Others".
cookielawinfo-checkbox-performance	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to store the user consent for cookies in the category "Performance".
CookieLawInfoConsent	1 year	Records the default button state of the corresponding category & the status of CCPA. It works only in coordination with the primary cookie.
PHPSESSID	session	This cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.

Requested Article:

Showing 15 citing articles:

Your Privacy